Pat Furlong

PPMD's Pat Furlong on BioCentury This Week

Thank you "BioCentury This Week" for having PPMD Founding President & CEO Pat Furlong on its 200th episode this weekend! You can watch Pat's segment online, where she shares her personal story in founding PPMD and why we will not rest until every person has a treatment to end Duchenne.
July 22, 2014 | Learn more

Research

No Exon Left Behind

PPMD has a decade-long history of supporting exon-skipping, but what exactly is it? How can we bring the technology to less common deletions and duplications as quickly as possible?
July 22, 2014 | Learn more 

Action Alert: Email

Action Alert! Key Senate Committee Schedules Markup for MD-CARE Act

In a significant step forward, a key Senate committee has announced that it will consider the MD-CARE Act Amendments on Wednesday, July 23rd.  We need all members of the Senate to know how important advancing this bill is to our community. Please take a moment to email your Senators and ask your friends and family to do the same.
July 17, 2014 | Take action 

News Update - eNews

End Duchenne eNews: Awarding Grants, Recognizing Progress, Welcoming Leadership

Catch up on the latest research and community updates in this month's End Duchenne eNews.
July 16, 2014 | Learn more 

one-step-closer-nws

One Step Closer

Progress! Today the House Energy & Commerce committee voted unanimously to advance H.R. 594, the MD-CARE Act Amendments of 2014. This action moves the bill to consideration and hopefully passage by the full House of Representatives.
July 15, 2014 | Learn more 

Pat's Blog

PPMD President Testifies Before Key Congressional Committee

Pat Furlong, Founding President and CEO of Parent Project Muscular Dystrophy will testify before the House Energy and Commerce Committee’s Subcommittee on Health as part of the committee’s ongoing 21st Century Cures Initiative on July 11 at 9am eastern. She is one of four patient advocacy representatives selected to testify in a hearing entitled “21st Century Cures: Incorporating the Patient Perspective."  
July 10, 2014 | Learn more 

 

News Update - Heart Health

PPMD and NHLBI Co-Sponsor Duchenne Cardiac Working Group

PPMD is thrilled to partner with the National Heart, Lung, and Blood Institute (NHLBI) to convene a working group titled “Contemporary Cardiac Issues in Duchenne Muscular Dystrophy.” The group, made up of top pediatric and adult cardiologists as well as clinical researchers, will meet this week to address critical evidence gaps in the understanding of cardiac issues in Duchenne.
July 9, 2014 | Learn more 

Pre-Conference Meeting

Outcomes Meeting: Laying a Foundation for Outcome Measures

At PPMD's pre-conference meeting, a group of therapists and industry representatives met to discuss the importance of standardizing outcome measures.
July 8, 2014 | Learn more 

conference-20-nws

Conference 20 Recap

Conference 20 included young men, parents, medical experts, academic researchers and companies, more than 16 companies talking about current trials or trials in development. We discussed compounds that target dystrophin (exon skipping and nonsense suppression) as well as compounds that ‘chip’ away at the downstream pathology- steroid replacement, anti-myostatin, anti-inflammatories, anti-fibrotics as well as new targets.
July 2, 2014 | Learn more 

porter-nws

PPMD Welcomes John Porter!

John Porter, PhD is a Program Director at the NIH/NINDS, responsible for managing a portfolio of research grants across neuromuscular disorders. John has agreed to join PPMD officially as of January 2015, to help us build upon current programs, expand the pipeline, and accelerate progress and approvals.
June 28, 2014 | Learn more 

ppmd-submits-nws

PPMD Submits FDA Draft Guidance on Duchenne

Today is a landmark day for PPMD and the entire Duchenne community. We are so pleased that at our organization’s 20 year anniversary after 2 decades of hard work and resolute persistence within the policy, legislative and regulatory arena we are today able to provide to the FDA the first-ever patient-initiated guidance to help accelerate development and review of potential therapies for Duchenne.
June 25, 2014 | Learn more 

 
Connect with PPMD
Facebook YouTube Twitter

 

Fund Research

Quick Links
PPMD Sites
Pat's Blog

Pat's BlogConference 20

The best part of the Connect Conference is being there, being together, connecting with the Duchenne community, the annual reunion. HOPE and CHANGE filled the air.

July 2, 2014 | Read more


Shop Amazon, End Duchenne

How We Help